Recalls / Active ingredient / Sumatriptan Succinate
Sumatriptan Succinate
3 FDA drug recalls involving the active ingredient “Sumatriptan Succinate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-04-13 | Class II | Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, | Mckesson Medical-Surgical Inc. Corporate Office |
| 2019-12-26 | Class II | Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b | Sun Pharmaceutical Industries, Inc. |
| 2013-11-06 | Class II | Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each | GlaxoSmithKline, LLC. |